FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217219934> ?p ?o ?g. }

• W3217219934 endingPage "1080" @default.
• W3217219934 startingPage "1066" @default.
• W3217219934 abstract "To describe the proposed mechanisms of chemotherapy-associated cardiomyopathy (CAC) and potential cardioprotective therapies for CAC including a comprehensive review of existing systematic analyses, guideline recommendations, and ongoing clinical trials.A literature search of MEDLINE was performed (from 1990 to June 2020) using the following search terms: anthracycline, trastuzumab, cardiomyopathy, cardiotoxicity, primary prevention, angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), beta blocker, dexrazoxane (DEX) as well as using individual names from select therapeutic categories.Existing English language systematic analyses and guidelines were considered.The mechanisms of CAC are multifaceted, but various cardioprotective therapies target many of these pathways. To date, anthracyclines and HER-2 targeted therapies have been the focus of cardioprotective trials to date as they are the most commonly implicated therapies in CAC. While traditional neurohormonal antagonists (ACEIs, ARBs, and beta blockers) and DEX performed favorably in many small clinical trials, the quality of available evidence remains limited. Hence, major guidelines lack consensus on an approach to primary prevention of CAC. Given the uncertain role of preventive therapy, monitoring for a symptomatic or asymptomatic decline in LV function is imperative with prompt evaluation should this occur. Numerous ongoing randomized controlled trials seek to either confirm the findings of these previous studies or identify new therapeutic agents to prevent CAC. Clinical implications are derived from the available literature as well as current guideline recommendations for CAC cardioprotection.At this time, no single therapy has a clear cardioprotective benefit in preventing CAC nor is any therapy strongly recommended by current guidelines. Additional studies are needed to determine the optimal preventative regimens." @default.
• W3217219934 created "2021-12-06" @default.
• W3217219934 creator A5003043496 @default.
• W3217219934 creator A5014109040 @default.
• W3217219934 creator A5027292867 @default.
• W3217219934 creator A5027869071 @default.
• W3217219934 creator A5090164871 @default.
• W3217219934 date "2021-11-22" @default.
• W3217219934 modified "2023-09-24" @default.
• W3217219934 title "Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies" @default.
• W3217219934 cites W1588049963 @default.
• W3217219934 cites W1931396297 @default.
• W3217219934 cites W1967139008 @default.
• W3217219934 cites W1977510259 @default.
• W3217219934 cites W1978030865 @default.
• W3217219934 cites W1978983696 @default.
• W3217219934 cites W1996063013 @default.
• W3217219934 cites W1998141986 @default.
• W3217219934 cites W1998659550 @default.
• W3217219934 cites W2013330212 @default.
• W3217219934 cites W2013913095 @default.
• W3217219934 cites W2020699761 @default.
• W3217219934 cites W2027587146 @default.
• W3217219934 cites W2066023275 @default.
• W3217219934 cites W2068629015 @default.
• W3217219934 cites W2088268131 @default.
• W3217219934 cites W2090295140 @default.
• W3217219934 cites W2097994998 @default.
• W3217219934 cites W2098268167 @default.
• W3217219934 cites W2099152902 @default.
• W3217219934 cites W2101253730 @default.
• W3217219934 cites W2105384253 @default.
• W3217219934 cites W2109634728 @default.
• W3217219934 cites W2109775164 @default.
• W3217219934 cites W2111511937 @default.
• W3217219934 cites W2112351355 @default.
• W3217219934 cites W2134242032 @default.
• W3217219934 cites W2142660045 @default.
• W3217219934 cites W2147646179 @default.
• W3217219934 cites W2153280957 @default.
• W3217219934 cites W2157687771 @default.
• W3217219934 cites W2164615567 @default.
• W3217219934 cites W2272185728 @default.
• W3217219934 cites W2284008279 @default.
• W3217219934 cites W2296878578 @default.
• W3217219934 cites W2530366440 @default.
• W3217219934 cites W2560560709 @default.
• W3217219934 cites W2746832929 @default.
• W3217219934 cites W2767053086 @default.
• W3217219934 cites W2791340070 @default.
• W3217219934 cites W2793072973 @default.
• W3217219934 cites W2800400752 @default.
• W3217219934 cites W2805254636 @default.
• W3217219934 cites W2888679886 @default.
• W3217219934 cites W2890462887 @default.
• W3217219934 cites W2896465321 @default.
• W3217219934 cites W2951406508 @default.
• W3217219934 cites W2969461497 @default.
• W3217219934 cites W2976106895 @default.
• W3217219934 cites W2998503649 @default.
• W3217219934 cites W2998958074 @default.
• W3217219934 cites W2999536665 @default.
• W3217219934 cites W3018708948 @default.
• W3217219934 cites W3083694235 @default.
• W3217219934 cites W3089951997 @default.
• W3217219934 cites W3118652086 @default.
• W3217219934 cites W3128646645 @default.
• W3217219934 cites W3165773896 @default.
• W3217219934 cites W3171709380 @default.
• W3217219934 cites W3196189025 @default.
• W3217219934 cites W4294605240 @default.
• W3217219934 cites W95894433 @default.
• W3217219934 doi "https://doi.org/10.1002/phar.2638" @default.
• W3217219934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34806206" @default.
• W3217219934 hasPublicationYear "2021" @default.
• W3217219934 type Work @default.
• W3217219934 sameAs 3217219934 @default.
• W3217219934 citedByCount "3" @default.
• W3217219934 countsByYear W32172199342021 @default.
• W3217219934 countsByYear W32172199342022 @default.
• W3217219934 crossrefType "journal-article" @default.
• W3217219934 hasAuthorship W3217219934A5003043496 @default.
• W3217219934 hasAuthorship W3217219934A5014109040 @default.
• W3217219934 hasAuthorship W3217219934A5027292867 @default.
• W3217219934 hasAuthorship W3217219934A5027869071 @default.
• W3217219934 hasAuthorship W3217219934A5090164871 @default.
• W3217219934 hasConcept C121608353 @default.
• W3217219934 hasConcept C126322002 @default.
• W3217219934 hasConcept C142724271 @default.
• W3217219934 hasConcept C143998085 @default.
• W3217219934 hasConcept C177713679 @default.
• W3217219934 hasConcept C2776694085 @default.
• W3217219934 hasConcept C2776802502 @default.
• W3217219934 hasConcept C2778198053 @default.
• W3217219934 hasConcept C2778233292 @default.
• W3217219934 hasConcept C2778797674 @default.
• W3217219934 hasConcept C2779720357 @default.
• W3217219934 hasConcept C2780182762 @default.

• next